SMRT compounds correct nonsense mutations in primary immunodeficiency and other genetic models

Por Gatti, Richard A.
Publicado em 2012

New approaches to treatment of primary immunodeficiencies: fixing mutations with chemicals

Por Hu, Hailiang, Gatti, Richard A.
Publicado em 2008

Progress toward therapy with antisense-mediated splicing modulation

Por Du, Liutao, Gatti, Richard A.
Publicado em 2009

Potential therapeutic applications of antisense morpholino oligonucleotides in modulation of splicing in primary immunodeficiency diseases

Por Du, Liutao, Gatti, Richard A.
Publicado em 2010

MicroRNAs: new players in the DNA damage response

Por Hu, Hailiang, Gatti, Richard A.
Publicado em 2011

A proposed bailout for A-T patients?

Por Gatti, Richard A., Perlman, Susan
Publicado em 2009

Pathogenesis of ataxia-telangiectasia: the next generation of ATM functions

Por Ambrose, Mark, Gatti, Richard A.
Publicado em 2013

Clinical Radiation Sensitivity with DNA Repair Disorders: An Overview

Por Pollard, Julianne M., Gatti, Richard A.
Publicado em 2009

Correction of prototypic ATM splicing mutations and aberrant ATM function with antisense morpholino oligonucleotides

Por Du, Liutao, Pollard, Julianne M., Gatti, Richard A.
Publicado em 2007

Deep-intronic ATM mutation detected by genomic resequencing and corrected in vitro by antisense morpholino oligonucleotide (AMO)

Por Cavalieri, Simona, Pozzi, Elisa, Gatti, Richard A, Brusco, Alfredo
Publicado em 2013

A frequent human CD20 (B1) differentiation antigen DNA polymorphism detected with MspI is located near 11q12–13

Por Charmley, Patrick, Nguyen, Julie, Tedder, Thomas F., Gatti, Richard A.
Publicado em 1990

Rapid Flow Cytometry–Based Structural Maintenance of Chromosomes 1 (SMC1) Phosphorylation Assay for Identification of Ataxia-Telangiectasia Homozygotes and Heterozygotes

Por Nahas, Shareef A., Butch, Anthony W., Du, Liutao, Gatti, Richard A.
Publicado em 2009

ATM is down-regulated by N-Myc–regulated microRNA-421

Por Hu, Hailiang, Du, Liutao, Nagabayashi, Gindy, Seeger, Robert C., Gatti, Richard A.
Publicado em 2010

Stable Brain ATM Message and Residual Kinase-Active ATM Protein in Ataxia-Telangiectasia

Por Li, Jiali, Chen, Jianmin, Vinters, Harry V., Gatti, Richard A., Herrup, Karl
Publicado em 2011

Assessing ‘Radiosensitivity’ with kinetic profiles of γ-H2AX, 53BP1 and BRCA1 Foci

Por Martin, Nathan T., Nahas, Shareef A., Tunuguntla, Rashmi, Fike, Francesca, Gatti, Richard A.
Publicado em 2011

Susceptibility of Cells from Patients with Primary Immunodeficiency Diseases to Transformation by Simian Virus 40

Por Kersey, John H., Gatti, Richard A., Good, Robert A., Aaronson, Stuart A., Todaro, George J.
Publicado em 1972

Repair of UV photolesions in xeroderma pigmentosum group C cells induced by translational readthrough of premature termination codons

Por Kuschal, Christiane, DiGiovanna, John. J., Khan, Sikandar G., Gatti, Richard A., Kraemer, Kenneth H.
Publicado em 2013

Arginine-rich cell-penetrating peptide dramatically enhances AMO-mediated ATM aberrant splicing correction and enables delivery to brain and cerebellum

Por Du, Liutao, Kayali, Refik, Bertoni, Carmen, Fike, Francesca, Hu, Hailiang, Iversen, Patrick L., Gatti, Richard A.
Publicado em 2011

Mass Spectrometry-Based Tissue Imaging of Small Molecules

Por Ferguson, Carly N., Fowler, Joseph W.M., Waxer, Jonathan F., Gatti, Richard A., Loo, Joseph A.
Publicado em 2014

MAGE-B2 AUTOANTIBODY: A NEW BIOMARKER FOR PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS

Por Hoftman, Alice DC, Tai, Lei-Qian, Tze, Sheila, Seligson, David, Gatti, Richard A, McCurdy, Deborah K
Publicado em 2008